A single-stranded DNA cytosine deaminase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9GZX7]
EC 3.5.4.38;
Activation-induced cytidine deaminase;
AID;
Cytidine aminohydrolase
Timeframe | Studies on this Protein(%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0) | 18.7374 |
1990's | 0 (0) | 18.2507 |
2000's | 0 (0) | 29.6817 |
2010's | 0 (0) | 24.3611 |
2020's | 0 (0) | 2.80 |
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
---|---|---|---|---|---|
hydroxylamine | Homo sapiens (human) | Potency | 49.2215 | 2 | 0 |
aurintricarboxylic acid | Homo sapiens (human) | Potency | 79.3735 | 2 | 0 |
chelerythrine | Homo sapiens (human) | Potency | 50.1187 | 1 | 0 |
dequalinium | Homo sapiens (human) | Potency | 89.1251 | 2 | 0 |
diphenyleneiodonium | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
dipyridamole | Homo sapiens (human) | Potency | 79.4328 | 1 | 0 |
2,3-dimethoxy-1,4-naphthoquinone | Homo sapiens (human) | Potency | 55.3026 | 2 | 0 |
hydralazine | Homo sapiens (human) | Potency | 38.7284 | 2 | 0 |
phenelzine | Homo sapiens (human) | Potency | 45.4947 | 2 | 0 |
beta-lapachone | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
mitoxantrone | Homo sapiens (human) | Potency | 33.6698 | 2 | 0 |
protoporphyrin ix | Homo sapiens (human) | Potency | 53.3427 | 2 | 0 |
sanguinarine | Homo sapiens (human) | Potency | 50.1187 | 1 | 0 |
tyrphostin a9 | Homo sapiens (human) | Potency | 70.7946 | 1 | 0 |
1-naphthaldehyde | Homo sapiens (human) | Potency | 56.2341 | 1 | 0 |
pyrazolanthrone | Homo sapiens (human) | Potency | 79.4328 | 1 | 0 |
2,3,5-trimethylquinol | Homo sapiens (human) | Potency | 50.1187 | 1 | 0 |
idarubicin | Homo sapiens (human) | Potency | 67.1545 | 2 | 0 |
flupirtine | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
masoprocol | Homo sapiens (human) | Potency | 44.6684 | 1 | 0 |
2-(4-aminophenyl)quinoline | Homo sapiens (human) | Potency | 56.2341 | 1 | 0 |
IPA-3 | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
2-[[2-methyl-5-(3-methyl-4-oxo-1-phthalazinyl)phenyl]sulfonylamino]acetic acid ethyl ester | Homo sapiens (human) | Potency | 89.1251 | 1 | 0 |
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine) | Homo sapiens (human) | Potency | 9.6681 | 2 | 0 |
nemadipine-a | Homo sapiens (human) | Potency | 50.1187 | 1 | 0 |
5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole | Homo sapiens (human) | Potency | 89.1251 | 1 | 0 |
ro 41-0960 | Homo sapiens (human) | Potency | 100.0000 | 1 | 0 |
tectochrysin | Homo sapiens (human) | Potency | 100.0000 | 1 | 0 |
casein kinase ii | Homo sapiens (human) | Potency | 89.1251 | 1 | 0 |
2-(2-methoxyanilino)-8-[(3-methyl-1-piperidinyl)-oxomethyl]-[1,3,4]thiadiazolo[2,3-b]quinazolin-5-one | Homo sapiens (human) | Potency | 89.1251 | 1 | 0 |
CDN1163 | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
hispidin | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-[[(4-oxo-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-2-yl)thio]methyl]benzoic acid methyl ester | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
This protein enables 6 target(s):
Target | Category | Definition |
---|---|---|
cytidine deaminase activity | molecular function | Catalysis of the reaction: cytidine + H+ + H2O = uridine + NH4 and deoxycytidine + H+ + H2O = deoxyuridine + NH4+. [EC:3.5.4.5] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
zinc ion binding | molecular function | Binding to a zinc ion (Zn). [GOC:ai] |
ubiquitin protein ligase binding | molecular function | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. [GOC:vp] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
RNA binding | molecular function | Binding to an RNA molecule or a portion thereof. [GOC:jl, GOC:mah] |
This protein is located in 3 target(s):
Target | Category | Definition |
---|---|---|
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
This protein is active in 3 target(s):
Target | Category | Definition |
---|---|---|
nucleus | cellular component | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. [GOC:go_curators] |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
P-body | cellular component | A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing. [GOC:clt, PMID:12730603] |
This protein is part of 1 target(s):
Target | Category | Definition |
---|---|---|
protein-containing complex | cellular component | A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together. [GOC:dos, GOC:mah] |
This protein is involved in 15 target(s):
Target | Category | Definition |
---|---|---|
mRNA processing | biological process | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. [GOC:mah] |
cytidine deamination | biological process | The removal of amino group in the presence of water. [GOC:sm] |
somatic diversification of immunoglobulins | biological process | The somatic process that results in the generation of sequence diversity of immunoglobulins. [GOC:add, GOC:ma, ISBN:0781735149] |
somatic hypermutation of immunoglobulin genes | biological process | Mutations occurring somatically that result in amino acid changes in the rearranged V regions of immunoglobulins. [GOC:add, ISBN:0781735149, PMID:11205330, PMID:11205333, PMID:14975236, PMID:7813007] |
B cell differentiation | biological process | The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity. [GO_REF:0000022, GOC:mah] |
regulation of nuclear cell cycle DNA replication | biological process | Any process that modulates the frequency, rate or extent of The DNA-dependent DNA replication that occurs in the nucleus of eukaryotic organisms as part of the cell cycle. [GOC:mtg_cell_cycle] |
defense response to bacterium | biological process | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. [GOC:jl] |
positive regulation of gene expression via chromosomal CpG island demethylation | biological process | An epigenetic gene regulation mechanism that positively regulates gene expression by demethylation of cytosine residues in chromosomal CpG islands. CpG islands are genomic regions that contain a high frequency of the CG dinucleotide and are often associated with the transcription start site of genes. [PMID:36150101, Wikipedia:Cpg_island] |
isotype switching | biological process | The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus. [ISBN:0781735149] |
cellular response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:mah] |
DNA cytosine deamination | biological process | The removal of an amino group from a cytosine residue in DNA, forming a uracil residue. [GOC:mah] |
DNA demethylation | biological process | The removal of a methyl group from one or more nucleotides within an DNA molecule. [PMID:17208187] |
cytidine to uridine editing | biological process | The conversion of a cytosine residue to uridine in an RNA molecule by deamination. [PMID:11092837] |
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of single stranded viral RNA replication via double stranded DNA intermediate. [GOC:go_curators] |
defense response to virus | biological process | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. [GOC:ai] |